Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2021-02-21Clinical Trial Update: Cognitive Behavioral Therapy to Treat Insomnia in Persons With HIV Infection [NA]
A completed clinical trial evaluating cognitive behavioral therapy for treating insomnia in people with HIV infection; results posted.
-
FDA approval · 2021-02-08FDA Approved: FLURAZEPAM HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Flurazepam hydrochloride (generic) filed by Chartwell RX, LLC.
-
FDA approval · 2021-02-08FDA Approved: FLURAZEPAM HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Flurazepam Hydrochloride filed by Chartwell RX, LLC. This action authorizes a modification t…
-
FDA approval · 2021-02-05FDA Approved: ESTAZOLAM — Supplemental Application (Novitium Pharma LLC)
FDA approves a supplemental application for Estazolam by Novitium Pharma LLC under ANDA074826.
-
FDA approval · 2021-02-05FDA Approved: ESTAZOLAM — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for ESTAZOLAM from Actavis Pharma, Inc. for a revised/expanded labeling and/or indication of this ge…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-02-05FDA Approved: HALCION — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for HALCION (triazolam) submitted by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2021-02-05FDA Approved: RESTORIL — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Restoril (temazepam) submitted by SpecGx LLC.
-
FDA label_change · 2021-02-05FDA Approved: ATIVAN — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for ATIVAN (lorazepam) submitted by Bausch Health US LLC, resulting in a labeling change for the…
-
FDA approval · 2021-02-05FDA Approved: ESTAZOLAM — Supplemental Application (Dr. Reddy's Labratories Inc.)
The FDA approved a supplemental application for Estazolam (ESTAZOLAM) from Dr. Reddy's Laboratories Inc.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Study to Assess the Pharmacodynamic Interaction Between Gabapentin and Ethanol in Healthy Subjects [Phase 4]
Phase 4 trial updating on pharmacodynamic interaction between gabapentin and ethanol in healthy subjects; completed.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Implementing and Evaluating Computer-Based Interventions for Mental Health: Testing an Implementation Strategy for VA Outpatient Care [NA]
Completed clinical trial evaluating computer-based interventions for mental health in VA outpatient care, focusing on insomnia and implement…
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial [Phase 4]
Phase 4 randomized trial evaluating a neurostimulation device for insomnia; status is active not recruiting.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Cognitive Behavioral Therapy for Insomnia for Gulf War Illness [NA]
A completed clinical trial evaluating Cognitive Behavioral Therapy for Insomnia for Gulf War Illness; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Eszopiclone in the Treatment of Insomnia and Fibromyalgia [Phase 4]
Phase 4 clinical trial update on eszopiclone for fibromyalgia and insomnia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia [Phase 2]
Phase 2 trial update for APD125 in patients with sleep maintenance insomnia has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Brief Behavioral Intervention for Insomnia During Chemotherapy [NA]
A completed clinical trial assessing a brief behavioral intervention for insomnia during chemotherapy in breast cancer patients, with result…
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Z-Drugs for Sleep Disorders in Alzheimer's Disease [Phase 3]
Phase 3 trial update on Z-Drugs for sleep disorders in Alzheimer's disease completed.
-
FDA approval · 2020-10-29FDA Approved: SILENOR — Supplemental Application (Currax Pharmaceuticals LLC)
FDA approved a supplemental application for SILENOR (doxepin hydrochloride) submitted by Currax Pharmaceuticals LLC.
-
FDA approval · 2020-10-26FDA Approved: RAMELTEON — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved an original ANDA for ramelteon from Upsher-Smith Laboratories, enabling a generic ramelteon product to reach the market. Ramelt…
-
FDA approval · 2020-10-20FDA Approved: TRIAZOLAM — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved a generic version of triazolam (Ingenus Pharmaceuticals, LLC) under ANDA 214219.
-
FDA approval · 2020-08-25FDA Approved: DAYVIGO — Supplemental Application (Eisai Inc.)
The FDA approved a supplemental application for DAYVIGO (lemorexant) submitted by Eisai Inc.
-
FDA approval · 2020-08-21FDA Approved: RAMELTEON — Original Application (Granules Pharmaceuticals Inc.)
The FDA approved a generic ramelteon product from Granules Pharmaceuticals Inc. for treatment of insomnia, expanding access to this sleep-on…
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Efficacy of CES in New Mothers During the Post Partum Period [NA]
Clinical trial update on the efficacy of CES (cranial electrostimulation) in new mothers during the postpartum period; study terminated with…
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Implementation of Brief Insomnia Treatments - Clinical Trial [NA]
A completed clinical trial from VA Pittsburgh Healthcare System evaluating brief insomnia treatments for chronic insomnia; results posted in…
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: The Efficacy of CBT-I in Alcoholics & Its Effects on Remission & Relapse [NA]
A completed clinical trial evaluating cognitive behavioral therapy for insomnia (CBT-I) in individuals with alcohol use disorder, with resul…